课题基金 / 基金详情

SPORE in Skin Cancer

SPORE in Skin Cancer
皮肤癌中的孢子
批准号:
6420221
负责人:
THOMAS S. KUPPER
金额:
$271.3万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2006-08-31

项目摘要

项目成果

THOMAS S. KUPPER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this proposal, we seek to establish a Specialized Program of Research Excellence (SPORE) in Skin Cancer at Harvard University and Brigham and Women's Hospital, within the newly configured Dana Farber Harvard Cancer Center. The Dana-Farber Harvard Cancer Center SPORE includes investigators from Harvard Medical School and School of Public Health, as well as the Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Children's Hospital Medical Center, Dana- Farber Cancer Institute, and the Massachusetts General Hospital. These institutions have come together around the theme of translational research in melanoma and cutaneous oncology Five Projects, five Shared Resources (Cores), a Developmental Program, and a Cancer Development Program are proposed. Project 1 will translate epidemiologic findings into the Development of improved risk models for melanoma; once developed, these will be validated across a large patient population. Project 2 employs the power of whole genome transcriptional profiling with the ultimate goal of improving our ability to diagnose and predict the biological course of primary melanoma. Project 3 tests the hypothesis that cutaneous T cell lymphoma is a malignancy of a population of memory T cells that normally performs immunosurveillance of the skin, and seeks to identify new targets for therapy. Projects 4 and 5 are exciting translational clinical trials. In Project 4, two diametrically different dendritic cell vaccination strategies are directly compared, using novel immunological endpoints.. In Project 5, biochemotherapeutic approaches are employed to treat metastatic melanoma. Immunologic monitoring will be performed again with the goal of improving therapy for melanoma patients. These five Projects are integrated by five Cores. The Biostatistics Core provides expert consultation to each study while the Tissue and Pathology Core provides controlled and organized access to tissue vital for these projects. An assessment of immunologic endpoints. The Clinical Data Management Core provides a vital service of creating dynamic and flexible databases that integrate Projects across multiple Harvard-affiliated hospitals. Finally, a Development Program features five projects, each of which is a candidate for evolution into a full project is promising translational results are obtained. A Career Development Program, which takes a broad view of the development of the physician scientist over the course of a career, is a centerpiece of this application. An administrative structure is in place that will assure oversight, integration, planning, didactic activities, and most importantly, the growth and evolution into a full project if promising translational results are obtained. A Career Development Program, which takes a broad view of the development of the physician scientist over the course of a career, is a centerpiece of this application. An administrative structure is in place that will assure oversight, integration, planning, didactic activities, and most importantly, the growth and evolution of the SPORE over the next five years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using the IL-1R1 and its ligands to optimize the T cell immune response to cancer
  • 批准号:
    10801033
  • 项目类别:
  • 资助金额:
    $61.87万
  • 财政年份:
    2023
  • 负责人:
    THOMAS S. KUPPER
  • 依托单位:
Skin Homing T Cells
  • 批准号:
    8827484
  • 项目类别:
  • 资助金额:
    $4.41万
  • 财政年份:
    2014
  • 负责人:
    THOMAS S. KUPPER
  • 依托单位:
Vaccination to generate protective tissue resident T cells
  • 批准号:
    8181512
  • 项目类别:
  • 资助金额:
    $112.4万
  • 财政年份:
    2011
  • 负责人:
    THOMAS S. KUPPER
  • 依托单位:
Harvard Skin Disease Research Center
  • 批准号:
    7666408
  • 项目类别:
  • 资助金额:
    $66.89万
  • 财政年份:
    2010
  • 负责人:
    THOMAS S. KUPPER
  • 依托单位:
海外基金